What is Cylerity?
Cylerity operates at the intersection of healthcare administration and financial services, providing a proprietary platform that accelerates cash flow for medical providers. The company addresses the systemic issue of delayed accounts receivable by offering advances of 70-90% on insurance and Medicare claims within a 48-hour window. Through the application of a sophisticated valuation algorithm, Cylerity mitigates the financial volatility typically associated with medical billing, allowing smaller practices to maintain operational stability. This service model effectively transforms stagnant receivables into immediate liquidity, streamlining the financial operations of healthcare businesses and reducing the administrative burden of revenue cycle management.
How much funding has Cylerity raised?
Cylerity has raised a total of $28M across 2 funding rounds:
Debt
$24M
Private Equity
$4M
Debt (2025): $24M with participation from First Business Bank
Private Equity (2025): $4M led by C2 Ventures, Wisconsin Investment Partners, First Business Bank, HealthX Ventures, and Tundra Angels
Key Investors in Cylerity
HealthX Ventures
A venture capital firm based in Madison, WI, specializing in digital health solutions that improve healthcare accessibility and efficiency.
First Business Bank
A bank holding company providing commercial banking and specialty finance solutions tailored to business executives and high-net-worth individuals.
C2 Ventures
An early-stage venture capital firm focused on AI-powered enterprise SaaS solutions and robotics for essential industrial sectors.
What's next for Cylerity?
With this major enterprise-level funding, Cylerity is poised to scale its proprietary valuation engine and expand its market reach. The strategic focus will likely shift toward enhancing the platform's predictive capabilities and deepening integration with existing electronic health record systems. As the company matures, the emphasis will remain on optimizing capital deployment to ensure that healthcare providers can focus on patient outcomes rather than cash flow management. Future growth trajectories suggest a potential expansion into broader specialty finance verticals, leveraging the firm's established credibility in the healthcare sector to capture additional market share in the medical fintech landscape.
See full Cylerity company page
